bioRxivCancer BiologyPreprint
Mapping the PTEN Mutation Landscape: Structural and Functional Drivers of Lung Cancer
Mohammad Uzzal HossainiD, Mohammad Nazmus SakibiD, Asma RahmaniD, SM Sajid Hasan, Nazia Hassan Nisha, Arittra BhattacharjeeiD, Zeshan Mahmud ChowdhuryiD, Ishtiaque AhammadiD, Keshob Chandra DasiD, Mohammad Shahedur RahmaniD, M. SalimullahiD
Abstract
Lung cancer is the predominant form of cancer globally, arising from the dysfunction of genetic mutations. Although PTEN mutation is crucial in the aetiology of lung cancer, the mapping of these major drivers has to be determined. We leverage computational algorithms on 43,855 SNPs of PTEN to discover the mutational impact contributing to lung cancer. Fifteen variations were identified as detrimental, and no pertinent studies have previously addressed their structural and functional aspects. Notably, seven variations were identified as the most significant contributors to lethal effects in functional aberration, as demonstrated by the computational assessment. Subsequently, molecular simulation elucidated the structural instability associated with these alterations. Furthermore, drug binding experiments at the mutational site corroborated the destabilization experiments by demonstrating the conformational alteration of the structure, resulting in varied amino acid interactions. In summary, the present study elucidates the influence of mutations in PTEN structure on its functional architecture.
- organism: human
- assay: DNA methylation
- assay: whole-exome sequencing
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lung cancer-enriched p53 mutants occupy canonical p53 target genes without activating transcription, revealing a distinct loss-of-function behavior
Mason Tracewell, Hailey N. Shankle, … Steven B. McMahon·bioRxiv·Feb 17, 2026
- Protein structural context of cancer mutations reveals molecular mechanisms and identifies novel candidate driver genes
Diego Chillón Pino, Mihaly Badonyi, … Joseph A. Marsh·bioRxiv·Mar 21, 2024
- How PTEN mutations degrade function at the membrane and life expectancy of carriers of mutations in the human brain
H. JANG, J. Chen, … R. Nussinov·bioRxiv·Jan 26, 2023
- PTEN mutant NSCLC require ATM to suppress pro-apoptotic signalling and evade radiotherapy
T. Fischer, O. Hartmann, … M. E. Diefenbacher·bioRxiv·Jul 24, 2021
- A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotypes relationships
Taylor L. Mighell, Sara Evans-Dutson, Brian J. O’Roak·The American Journal of Human GeneticsPeer-reviewed·Apr 26, 2018
- Induced mutagenesis by the DNA cytosine deaminase APOBEC3H Haplotype I protects against lung cancer
M. A. Hix, L. Wong, … G. A. Cisneros·bioRxiv·Feb 28, 2020